Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HROW

Harrow (HROW)

Harrow Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HROW
DateTimeSourceHeadlineSymbolCompany
27/01/202523:30Business WireHarrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their PatientsNASDAQ:HROWHarrow Inc
07/01/202523:00Business WireHarrow Appoints Amir H. Shojaei as Chief Scientific OfficerNASDAQ:HROWHarrow Inc
21/11/202423:00Business WireHarrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.NASDAQ:HROWHarrow Inc
20/11/202423:00Business WireMelt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract SurgeryNASDAQ:HROWHarrow Inc
15/11/202423:00Business WireHarrow Announces Participation in Upcoming Investor ConferencesNASDAQ:HROWHarrow Inc
14/11/202408:34Business WireHarrow Announces Third Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
13/11/202423:00Business WireHarrow Launches Access and Affordability Program with Price Reductions for Branded ProductsNASDAQ:HROWHarrow Inc
12/11/202423:00Business WireHarrow Announces Market Access Wins for VEVYE®NASDAQ:HROWHarrow Inc
07/11/202423:00Business WireHarrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare ProductsNASDAQ:HROWHarrow Inc
31/10/202422:00Business WireHarrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024NASDAQ:HROWHarrow Inc
10/10/202422:00Business WireMelt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract SurgeryNASDAQ:HROWHarrow Inc
03/10/202421:00Business WireHarrow Relaunches TRIESENCE®NASDAQ:HROWHarrow Inc
26/09/202402:02Business WireHarrow Announces Nashville ExpansionNASDAQ:HROWHarrow Inc
03/09/202421:00Business WireHarrow to Present at Three Investor Conferences in September in New YorkNASDAQ:HROWHarrow Inc
08/08/202407:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HROWHarrow Inc
08/08/202406:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
08/08/202406:01Business WireHarrow Announces Second Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
25/07/202421:00Business WireHarrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024NASDAQ:HROWHarrow Inc
12/07/202421:00Business WireHarrow to Attend 2024 ASRS Annual MeetingNASDAQ:HROWHarrow Inc
09/07/202421:00Business WireHarrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow ProductsNASDAQ:HROWHarrow Inc
20/06/202421:00Business WireHarrow Provides TRIESENCE® Relaunch UpdateNASDAQ:HROWHarrow Inc
06/06/202422:00Business WireMelt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract SurgeryNASDAQ:HROWHarrow Inc
05/06/202421:00Business WireHarrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension StudyNASDAQ:HROWHarrow Inc
15/05/202421:00Business WireHarrow to Present at Two Investor Conferences in MayNASDAQ:HROWHarrow Inc
14/05/202406:01Business WireHarrow Announces First Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
13/05/202421:00Business WireHarrow Names Greg DiPasquale as Senior Vice President, Head of CommercialNASDAQ:HROWHarrow Inc
25/04/202421:00Business WireHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024NASDAQ:HROWHarrow Inc
02/04/202423:16Business WireMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingNASDAQ:HROWHarrow Inc
20/03/202422:15IH Market NewsJPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest NewsNASDAQ:HROWHarrow Inc
20/03/202408:45Business WireHarrow Announces Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:HROWHarrow Inc
 Showing the most relevant articles for your search:NASDAQ:HROW